Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Westerhausen

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Treatment results of the thioether lipid ilmofosine in patients with malignant tumoursM Winkelmann, K Ebeling, G Strohmeyer, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemiasP S Mitrou, R Kuse, H Anger, et al.
Onkologie|February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer SocietyK Possinger, H Wagner, P Worst, et al.
Onkologie|June 1, 1984
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)]A Liesenfeld, K Havemann, C Gropp, et al.
Deutsche Medizinische Wochenschrift (1946)|August 16, 1991
[Malignant lymphoma associated with HIV infection]P S Mitrou, M Serke, C Pohl, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1985
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesineH W von Heyden, M Schröder, A Scherpe, et al.
Onkologie|June 1, 1983
[2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]M Schröder, H W von Heyden, A Scherpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancerC H Köhne, P Schöffski, H Wilke, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinomaW Queisser, G Schnitzler, J Schaefer, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Treatment results of the thioether lipid ilmofosine in patients with malignant tumoursM Winkelmann, K Ebeling, G Strohmeyer, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemiasP S Mitrou, R Kuse, H Anger, et al.
Onkologie|February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer SocietyK Possinger, H Wagner, P Worst, et al.
Onkologie|June 1, 1984
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)]A Liesenfeld, K Havemann, C Gropp, et al.
Deutsche Medizinische Wochenschrift (1946)|August 16, 1991
[Malignant lymphoma associated with HIV infection]P S Mitrou, M Serke, C Pohl, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1985
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesineH W von Heyden, M Schröder, A Scherpe, et al.
Onkologie|June 1, 1983
[2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]M Schröder, H W von Heyden, A Scherpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancerC H Köhne, P Schöffski, H Wilke, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinomaW Queisser, G Schnitzler, J Schaefer, et al.
Pageof 6